The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Data showing a sharp drop in the number of federal prosecutions of suspected drug dealers in San Francisco calls into ...
The U.S. Food and Drug Administration is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy ...
Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
A menopause researcher breaks down the biggest myths women get wrong about hot flashes, plus the hormonal and non-hormonal ...
President Donald Trump has repeatedly claimed that strikes on suspected drug boats his administration began carrying out in ...
The Trump administration earlier this week carried out the 20th attack against alleged narco-terrorists in the Caribbean Sea, ...
Two "priority targets" of the U.S. DEA as well as suspected members of the Italian mafia were among 20 people detained, ...
(WJW) – The recall of a baby formula believed to be linked to multiple botulism cases is now being expanded to include all ...
The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...
Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...